Back
Ingevity Corp. 10K Form
Buy
64
NGVT
Ingevity Corp.
Last Price:
$71.09
Seasonality Move:
4.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-07-30 | 10Q | NGVT/Ingevity Corp. Quarterly |
| 2020-04-30 | 10Q | NGVT/Ingevity Corp. Quarterly |
| 2020-02-26 | 10K | NGVT/Ingevity Corp. Annual |
| 2019-10-30 | 10Q | NGVT/Ingevity Corp. Quarterly |
| 2019-07-31 | 10Q | NGVT/Ingevity Corp. Quarterly |
| 2019-05-02 | 10Q | NGVT/Ingevity Corp. Quarterly |
Receive NGVT News And Ratings
See the #1 stock for the next 7 days that we like better than NGVT
NGVT Financial Statistics
Sales & Book Value
| Annual Sales: | $1.2B |
|---|---|
| Cash Flow: | $73.8M |
| Price / Cash Flow: | 9.31 |
| Annual Sales: | $0.84 |
| Price / Book: | 82.92 |
Profitability
| EPS (TTM): | -4.65140 |
|---|---|
| Net Income (TTM): | $-164M |
| Gross Margin: | $431.5M |
| Return on Equity: | -114.16% |
| Return on Assets: | -8.69% |
Ingevity Corp. Earnings Forecast
Key Ingevity Corp. Financial Ratios
-
The Gross Profit Margin over the past 14 years for NGVT is 36.95%.
-
The Selling, General & Administrative Expenses for NGVT have been equal to 14.66% of Gross Profit Margin.
-
The Research & Development expenses have been 2.43% of Revenue.
-
The Net Earning history of NGVT is -12.87% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 7 years.
Ingevity Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | NGVT |
| CUSIP: | 45688C |
| Website: | ingevity.com |
Debt
| Debt-to-Equity Ratio: | 41.84 |
|---|---|
| Current Ratio: | 1.33 |
| Quick Ratio: | 0.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 11.69 |
NGVT Technical Analysis vs Fundamental Analysis
Buy
64
Ingevity Corp. (NGVT)
is a Buy
Is Ingevity Corp. a Buy or a Sell?
-
Ingevity Corp. stock is rated a BuyThe current Ingevity Corp. [NGVT] share price is $71.09. The Score for NGVT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.